Importantly, the use of mitochondria-targeting peptides directed to the IF1–OSCP interaction or to the C-terminal region of the OSCP subunit mimic or counteract, respectively, the effects of the high levels of IF1 in HeLa cancer cells by modulating the PTP opening. This evidence concerns the gene ATP5IF1 and cancer.